RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background: Angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine subtype 2 (TMPRSS2) are key proteins mediating viral entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although gene expressions of ACE2 and TMPRSS2 have been analyzed in various organs and diseases, their soluble forms have been less studied, particularly in asthma. Therefore, we aimed to measure circulating ACE2 and TMPRSS2 in the serum of asthmatics and examine their relationship with clinical characteristics.
Methods: Clinical data and serum samples of 400 participants were obtained from an asthma cohort. The soluble ACE2 (sACE2) and soluble TMPRSS2 (sTMPRSS2) level was measured by enzyme-linked immunosorbent assay, and the values underwent a natural log transformation. Associations between sACE2 and TMPRSS2 levels and various clinical variables were analyzed.
Results: The patients younger than 70 years old, those with eosinophilic asthma (eosinophils ≥ 200 cells/µL), and inhaled corticosteroids (ICS) non-users were associated with higher levels of sACE2. Blood eosinophils and fractionated exhaled nitric oxide levels were positively correlated with serum ACE2. In contrast, lower levels of sTMPRSS2 were noted in patients below 70 years and those with eosinophilic asthma, while no association was noted between ICS use and sTMPRSS2. The level of sTMPRSS2 also differed according to sex, smoking history, coexisting hypertension, and forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio. The proportion of sputum neutrophils was positively correlated with sTMPRSS2, while the FEV1/FVC ratio reported a negative correlation with sTMPRSS2.
Conclusion: The levels of ACE2 and TMPRSS2 were differently expressed according to age, ICS use, and several inflammatory markers. These findings suggest variable susceptibility and prognosis of SARS-CoV-2 infection among asthmatic patients.

참고문헌 (Reference)

1 Sanchez-Ramirez DC, "Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes : a systematic review and meta-analysis" 171 : 106096-, 2020

2 Kimura H, "Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells" 146 (146): 80-88.e8, 2020

3 Kermani NZ, "Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma" 22 (22): 10-, 2021

4 Emilsson V, "Serum levels of ACE2 are higher in patients with obesity and diabetes" 7 (7): 239-243, 2020

5 Pavel AB, "SARS-CoV-2 receptor ACE2protein expression in serum is significantly associated with age" 76 (76): 875-878, 2021

6 Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor" 181 (181): 271-280.e8, 2020

7 Wu C, "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China" 180 (180): 934-943, 2020

8 Kornilov SA, "Plasma levels of soluble ACE2are associated with sex, metabolic syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19" 24 (24): 452-, 2020

9 Park SY, "Novel trajectories for identifying asthma phenotypes : a longitudinal study in Korean asthma cohort, COREA" 7 (7): 1850-1857.e4, 2019

10 Davidson AM, "Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications" 76 (76): 1339-1349, 2020